Search our team at AdventHealth Research Institute
Showing 1 - 4 of 4 clinical trials matching your search
-
Treatment of Bone Marrow Failure, Post Allogeneic Bone Marrow Transplant,w ith CD34+ Cell-Enriched Hematopoietic Stem Cell Infusion (Miltenyi Biotec's CliniMACS CD34 Reagent System) A HDE Treatment Protocol
This study is not currently enrolling.Associated Conditions: Multiple Tumor TypesResearch Area: Clinical Cancer Research[Shell Only] - HUD/CUD.
-
NCT05653271
A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ACE1831, an Allogeneic CD20-conjugated gamma delta T-cell therapy, in Adult Subjects with Relapsed/Refractory CD20-expressing B-cell Malignancies
This study is currently enrolling.Associated Conditions: Bone CancerResearch Area: Clinical Cancer ResearchA Phase 1 Multicenter Study Evaluating the Safety and Efficacy of
ACE1831, an Allogeneic CD20-conjugated gamma delta T-cell therapy, in Adult Subjects with Relapsed/Refractory CD20-expressing B-cell... -
A global Phase 3, open label, Randomized Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy vs the standard of care treatment in adult patients with high-risk, transplant-eligible Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma (ANTLER-Phase 3 [Part III])
This study is not currently enrolling.Associated Conditions: Bone CancerResearch Area: Clinical Cancer Research -
NCT05457556
A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma
This study is not currently enrolling.Associated Conditions: Bone CancerResearch Area: Pediatric Research and Clinical TrialsThis study looks at how well cabozantinib in combination with MAP work when given to children and young adults with newly diagnosed OST disease. Cabozantinib is experimental because it has not been...